Data from Pre-Clinical Study of Protalex's PRTX-100 Compound Presented at the 5th Int'l Conference on Autoimmunity in Sorrento, Italy
14th Nov 2006, 16:38 GMT
Protalex announced that Joe J Dervan, Ph.D, Dir of Protein Chemistry and Biopharmaceutical Manufacturing at Protalex, will present pre-clinical efficacy data from the collagen induced arthritis study of the Company's PRTX-100 compound in development for the treatment of autoimmune and inflammatory diseases, at the 5th Int'l Conference on Autoimmunity, taking place November 29- 12/3/2006, at the Hilton Sorrento Palace Hotel, in Sorrento, Italy.
Data from Pre-Clinical Study of Protalex's PRTX-100 Compound Presented at the 5th Int'l Conference on Autoimmunity in Sorrento, Italy related news:
- Data on PolyMedix's Novel Antibiotics Presented at the 40th Annual Meeting of the Ocular Microbiology and Immunology Group — Pharmaceuticals News from StratCenter.com
- Study: Anger could be deadly for some — United Press International - NewsTrack
- Enbrel provides sustained clinical improvements for ankylosing spondylitis for up to 3 years — EurekAlert! - Medicine and Health
- Alba Therapeutics Presents Data From Positive Phase Ib Clinical Trial At The XII International Celiac Disease Symposium — Health News from Medical News Today
- Interim Data on Use of tgAAC94 in the Treatment of Inflammatory Arthritis Presented at the American College of Rheumatology Meeting — Partnerships/ Joint Ventures News from StratCenter.com
- Targeted Genetics Corporation: Interim Data on Use of tgAAC94 in the Treatment of Inflammatory Arthritis Presented at the American College of Rheumatology Meeting — Market Wire - Pharmaceuticals and Biotech
- Clinical Data and Diagene in Cardiac Channelopathy Test Distribution Agreement for Germany, Switzerland and Austria — Cardiology News from StratCenter.com
- DSI To Host dcLINK Client Conference — People, places, contracts latest news on Manufacturingtalk
- Volcano Announces Clinical Review of Key Presentations From TCT 2006 — Cardiology News from StratCenter.com
- Cell-Phone Infertility — The Onion
Latest news from Bio-Technology News from StratCenter.com:
- IBT Labs Invests $2 mln to Expand Pharmaceutical Services Division
- Mercury Computer Systems Collaborates with Boston Univ to Deliver Biotech Application on the Cell BE Processor
- Nabi Biopharmaceuticals and 3rd Point Reach Agreement
- Epratuzumab and Rituximab Have Different Modes of Action
- avVaa World Health Care Products Signs New Spokesman
- China Biopharma Delivers 1.5 mln Doses of Flu Vaccine in China
- Osteologix Appoints Jeremy Curnock Cook to its Board
- Favrille Announces Interim Analysis of Secondary Endpoint from Pivotal Phase 3 Clinical Trial of FavId Following Rituxan in Follicular B-Cell Non-Hodgkin's Lymphoma
- Medarex to Receive Milestone Payment from Amgen
- Arqule Early Cancer Study Shows Progress